Q32 Bio Inc. Annual Earnings Per Share, Diluted in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Q32 Bio Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2021 to 2023.
  • Q32 Bio Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2024 was -1.46 USD/shares, a 96.4% increase year-over-year.
  • Q32 Bio Inc. Earnings Per Share, Diluted for the twelve months ending September 30, 2024 was 65.9 USD/shares.
  • Q32 Bio Inc. annual Earnings Per Share, Diluted for 2023 was -1.95 USD/shares, a 2067% decline from 2022.
  • Q32 Bio Inc. annual Earnings Per Share, Diluted for 2022 was -0.09 USD/shares, a 94.8% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 -$2 -2067% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $0 +$1.64 +94.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$2 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.